A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
Top Cited Papers
Open Access
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 135 (6), 1953-1960
- https://doi.org/10.1053/j.gastro.2008.08.057
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Dysregulated Cytokine Metabolism, Altered Hepatic Methionine Metabolism and Proteasome Dysfunction in Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 2005
- MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitisJournal of Hepatology, 2005
- MELD accurately predicts mortality in patients with alcoholic hepatitis†Hepatology, 2005
- Cellular Signaling Mechanisms in Alcohol-Induced Liver DamageSeminars in Liver Disease, 2004
- Model for end stage liver disease score predicts mortality across a broad spectrum of liver diseaseJournal of Hepatology, 2004
- Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot studyJournal of Hepatology, 2002
- Experience with etanercept in an academic medical center: Are infection rates increased?Arthritis & Rheumatism, 2002
- TNF‐α gene polymorphism: Clinical and biological implicationsMicroscopy Research and Technique, 2000
- S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trialJournal of Hepatology, 1999
- A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a department of veterans affairs cooperative studyHepatology, 1993